Dominantly Inherited Alzheimer Network (DIAN)
NCT00869817
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Alzheimer's Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Washington University School of Medicine
- Last updated on ClinicalTrials.gov
- October 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Mayo Clinic Jacksonville · Jacksonville, FL
Indiana · 1
- Indiana University-Indiana Alzheimer Disease Center · Indianapolis, IN
Massachusetts · 1
- Brigham and Women's Hospital · Boston, MA
Missouri · 1
- Washington University in St. Louis School of Medicine · St Louis, MO
Pennsylvania · 1
- University of Pittsburgh · Pittsburgh, PA
Rhode Island · 1
- Butler Hospital · Providence, RI
Washington · 1
- University of Washington · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.